logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Deciphera Pharmaceuticals, LLC


USPTO Granted Patents = 86



Trademarks = 5

Forward Citations = 2,565

Loading Chart...
Loading Chart...

44 inventors (with patents filed for the assignee):

goldMedal Daniel L Flynn (46 out of 125 patents)

silverMedal Michael D Kaufman (44 out of 48 patents)

bronzeMedal Scott Bone (20 out of 24 patents)

4.  Corey Bloom (20 out of 30 patents)

5.  Fred Jordan (20 out of 22 patents)

6.  Rodrigo Ruiz Soto (20 out of 20 patents)

7.  Peter Albert Petillo (18 out of 27 patents)

8.  Oliver Rosen (17 out of 17 patents)

9.  Jama Pitman (17 out of 17 patents)

10.  Lakshminarayana Vogeti (12 out of 20 patents)

11.  Timothy Malcolm Caldwell (11 out of 11 patents)

12.  Bryan D Smith (8 out of 10 patents)

13.  Yu Mi Ahn (7 out of 7 patents)

14.  William C Patt (6 out of 8 patents)

15.  Thiwanka Samarakoon (4 out of 4 patents)


Core Competencies:
Vimseltinib
VPS34 Inhibitors
Autophagy Inhibitors
Gastrointestinal Stromal Tumors
RAF Kinase Inhibitors
CSF1R Inhibitors
Combination Therapy
Amorphous Kinase Inhibitors
Phenylaminopyrimidine
Heteroarylaminopyrimidine
Kinase Inhibitors
Compositions of Phenylurea

86 patents:

1. 12509456 - Solid state forms of ripretinib (2025-12-30),
2. 12509443 - CSF-1R inhibitors and methods of use thereof (2025-12-30),
3. 12447149 - Formulations of vimseltinib (2025-10-21),
4. 12414955 - Anti-viral activity of VPS34 inhibitors (2025-09-16),
5. 12377097 - Aminopyrimidine amide autophagy inhibitors and methods of use thereof (2025-08-05),
6. 12319655 - RAF kinase inhibitors and methods of use thereof (2025-06-03),
7. 12318374 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-06-03),
8. 12318373 - Methods of treating gastrointestinal stromal tumors (2025-06-03),
9. 12295944 - Methods of treating gastrointestinal stromal tumors (2025-05-13),
10. 12285430 - Methods of treating disorders using CSF1R inhibitors (2025-04-29),
11. 12226406 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-18),
12. 12213968 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),
13. 12213967 - Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea (2025-02-04),
14. 12102620 - Combination therapy for the treatment of mastocytosis (2024-10-01),
15. 12071432 - Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof (2024-08-27),
Deciphera Pharmaceuticals, LLC is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of cancer patients. The company's approach involves targeting key kinase enzymes that are critical drivers of cancer cell growth and proliferation. Deciphera's innovative drug candidates are designed to selectively inhibit these kinases to halt tumor progression. With a commitment to rigorous science, Deciphera is dedicated to advancing precision medicine and making a meaningful impact in oncology.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

86 Patents

#12 in Waltham, MA

#228 in Massachusetts

#4,182 in US

#8,583 in the World

...
Waltham, MA, United States of America

Deciphera Pharmaceuticals, LLC

Forward Citations = 2,565

44 inventors:

goldMedal Daniel L Flynn (46 out of 125 patents)

silverMedal Michael D Kaufman (44 out of 48 patents)

bronzeMedal Scott Bone (20 out of 24 patents)

4.  Corey Bloom (20 out of 30 patents)

5.  Fred Jordan (20 out of 22 patents)

Please report any incorrect information to support@idiyas.com
Loading…